Cellectar Biosciences, Inc. (CLRB)
1.25
+0.10
(+8.70%)
USD |
NASDAQ |
Nov 06, 16:00
1.24
-0.01
(-0.80%)
After-Hours: 20:00
Cellectar Biosciences Price : 1.25 for Nov. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 06, 2026 | 1.13 | 1.276 | 1.125 | 1.25 | 76953.00 |
| Nov 05, 2026 | 1.21 | 1.27 | 1.11 | 1.15 | 144194.0 |
| Nov 04, 2026 | 1.28 | 1.37 | 1.23 | 1.23 | 87794.00 |
| Nov 03, 2026 | 1.24 | 1.31 | 1.227 | 1.31 | 140914.0 |
| Nov 02, 2026 | 1.23 | 1.255 | 1.18 | 1.22 | 66545.00 |
| Oct 30, 2026 | 1.205 | 1.205 | 1.18 | 1.205 | 55288.00 |
| Oct 29, 2026 | 1.22 | 1.26 | 1.19 | 1.22 | 111909.0 |
| Oct 28, 2026 | 1.22 | 1.26 | 1.20 | 1.24 | 58539.00 |
| Oct 27, 2026 | 1.23 | 1.29 | 1.16 | 1.21 | 161585.0 |
| Oct 26, 2026 | 1.25 | 1.27 | 1.19 | 1.21 | 184737.0 |
| Oct 23, 2026 | 1.19 | 1.22 | 1.14 | 1.22 | 58227.00 |
| Oct 22, 2026 | 1.28 | 1.28 | 1.17 | 1.17 | 68657.00 |
| Oct 21, 2026 | 1.25 | 1.33 | 1.23 | 1.28 | 134956.0 |
| Oct 20, 2026 | 1.13 | 1.24 | 1.12 | 1.23 | 109491.0 |
| Oct 19, 2026 | 1.18 | 1.20 | 1.12 | 1.12 | 195300.0 |
| Oct 16, 2026 | 1.19 | 1.28 | 1.12 | 1.14 | 341331.0 |
| Oct 15, 2026 | 1.21 | 1.27 | 1.15 | 1.19 | 382263.0 |
| Oct 14, 2026 | 1.44 | 1.465 | 1.15 | 1.18 | 395536.0 |
| Oct 13, 2026 | 1.55 | 1.60 | 1.36 | 1.39 | 539388.0 |
| Oct 12, 2026 | 1.45 | 1.47 | 1.40 | 1.43 | 186139.0 |
| Oct 09, 2026 | 1.41 | 1.49 | 1.37 | 1.45 | 91480.00 |
| Oct 08, 2026 | 1.57 | 1.57 | 1.34 | 1.40 | 169697.0 |
| Oct 07, 2026 | 1.55 | 1.62 | 1.47 | 1.51 | 42570.00 |
| Oct 06, 2026 | 1.66 | 1.729 | 1.46 | 1.51 | 219435.0 |
| Oct 05, 2026 | 1.79 | 1.79 | 1.67 | 1.67 | 60682.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 21.23 |
| Alnylam Pharmaceuticals, Inc. | 155.94 |
| Anika Therapeutics, Inc. | 14.55 |
| Savara, Inc. | 4.83 |
| Vericel Corp. | 54.62 |
Price Related Metrics
| Price to Book Value | 0.3453 |
| Earnings Yield | -364.3% |
| Market Cap | 10.32M |